Dr. Michael Zastrozhin, a distinguished leader in the field of pharmacogenetics, currently serves as the Chief Executive Officer of PGxAI, where he is at the forefront of revolutionizing precision medicine. With an impressive academic background that includes an MD, PhD, MPH, DMedSci, and a recent...
Dr. Michael Zastrozhin, a distinguished leader in the field of pharmacogenetics, currently serves as the Chief Executive Officer of PGxAI, where he is at the forefront of revolutionizing precision medicine. With an impressive academic background that includes an MD, PhD, MPH, DMedSci, and a recent postdoctoral fellowship, Dr. Z has cultivated a deep expertise in pharmacoepidemiology and personalized medicine. His role at PGxAI is pivotal as he drives the development of an AI-powered platform that leverages proprietary algorithms and extensive real-world data to enhance drug selection and dosage personalization for patients.
Under Dr. Z's leadership, PGxAI has embarked on key projects that harness the power of advanced tools such as VectorSearch and GenAI, in partnership with InterSystems, the largest holder of patient data globally. This collaboration enables PGxAI to access a vast array of clinical data, facilitating the identification of clinically relevant drug-drug interactions and optimizing treatment plans tailored to individual genetic profiles. Dr. Z's long-term vision for the company is to bridge the gap between complex genetic information and actionable insights in patient care, ultimately improving outcomes in addiction medicine and other therapeutic areas.
His unique blend of skills—ranging from data analysis and pharmacology to team leadership and business insights—positions him as a thought leader in the industry. Dr. Z's commitment to advancing personalized medicine not only enhances patient care but also sets a new standard for how healthcare providers approach pharmacotherapy in an increasingly complex medical landscape. As PGxAI continues to innovate, Dr. Z remains dedicated to ensuring that precision medicine becomes accessible and effective for all patients, paving the way for a healthier future.
